Brief: Inventiva SA Says Legend Achieves Primary Efficacy Endpoint In Lowering Hba1c
15/11/2024 21:01
Nov 15 (Reuters) - Inventiva SA IVAA.PA :
* INVENTIVA SA - LEGEND ACHIEVES PRIMARY EFFICACY ENDPOINT
IN
LOWERING HBA1C
Source text: ID:nGNE9bgxQD
Further company coverage: IVAA.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inventiva SA
See all newsFrance's Inventiva H1 net loss narrows
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Inventiva Announces Last Patient Visit In Nativ3 Phase 3 Clinical Trial Of Lanifibranor In Mash
Brief: Inventiva Announces Comprehensive Capital Structure Optimization Including Debt And Equity Financing In Advance Of The Anticipated Phase 3 Readout
Brief: Inventiva Secures Up To €150 Mln Debt Financing, Extends Debt Maturity To 2030